CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of canc ...
Add Yahoo as a preferred source to see more of our stories on Google. Treg cells have been thrust into the limelight thanks to the Nobel Prize-winning work of a team of researchers from the U.S. and ...
London, UK – 3 March, 2026 – Quell Therapeutics Ltd (“Quell”), today announced that it has initiated a Phase 1/2 basket clinical study evaluating ...
Regeneron Pharmaceuticals already has a presence in immunology, but nothing in its portfolio or pipeline addresses inflammatory bowel disorders nor does the drugmaker have any cell therapies. The ...
Terumo Blood and Cell Technologies has entered a new collaboration with Taiwan Bio Therapeutics to transition regulatory T‑cell manufacturing onto the automated Quantum Flex platform, marking a shift ...
GDAŃSK, Poland, March 10, 2026 (GLOBE NEWSWIRE) -- PolTREG SA (WSE: PTG), a pioneer and global leader in the development of therapies using T-regulatory lymphocytes (TREGs), announces that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results